Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Identification of a novel uterine leiomyoma GWAS locus in a Japanese population.

Sakai K, Tanikawa C, Hirasawa A, Chiyoda T, Yamagami W, Kataoka F, Susumu N, Terao C, Kamatani Y, Takahashi A, Momozawa Y, Hirata M, Kubo M, Fuse N, Takai-Igarashi T, Shimizu A, Fukushima A, Kadota A, Arisawa K, Ikezaki H, Wakai K, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Aoki D, Matsuda K.

Sci Rep. 2020 Jan 27;10(1):1197. doi: 10.1038/s41598-020-58066-8.

2.

SPHK1 Is a Novel Target of Metformin in Ovarian Cancer.

Hart PC, Chiyoda T, Liu X, Weigert M, Curtis M, Chiang CY, Loth R, Lastra R, McGregor SM, Locasale JW, Lengyel E, Romero IL.

Mol Cancer Res. 2019 Apr;17(4):870-881. doi: 10.1158/1541-7786.MCR-18-0409. Epub 2019 Jan 17.

PMID:
30655321
3.

PARP inhibitors and quality of life in ovarian cancer.

Aoki D, Chiyoda T.

Lancet Oncol. 2018 Aug;19(8):1012-1014. doi: 10.1016/S1470-2045(18)30435-2. Epub 2018 Jul 17. No abstract available.

PMID:
30026001
4.

Development of pseudoaneurysm in cesarean section scar pregnancy: a case report and literature review.

Kiyokawa S, Chiyoda T, Ueno K, Saotome K, Kim SH, Nakada S.

J Med Ultrason (2001). 2018 Apr;45(2):357-362. doi: 10.1007/s10396-017-0836-z. Epub 2017 Nov 16. Review.

PMID:
29147816
5.

Hysteroscopic Transcervical Resection for Atypical Polypoid Adenomyoma of the Uterus: A Valid, Fertility-Preserving Option.

Chiyoda T, Lin BL, Saotome K, Kiyokawa S, Nakada S.

J Minim Invasive Gynecol. 2018 Jan;25(1):163-169.e1. doi: 10.1016/j.jmig.2017.08.659. Epub 2017 Oct 13.

PMID:
29038039
6.

Elevated preoperative neutrophil : lymphocyte ratio as a preoperative indicator of mature cystic teratoma with malignant transformation.

Nanki Y, Chiyoda T, Kataoka F, Nomura H, Nakadaira N, Iwasa N, Hashimoto S, Arima H, Susumu N, Aoki D.

J Obstet Gynaecol Res. 2017 Apr;43(4):744-748. doi: 10.1111/jog.13271. Epub 2017 Mar 28.

7.

Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention.

Chiyoda T, Hart PC, Eckert MA, McGregor SM, Lastra RR, Hamamoto R, Nakamura Y, Yamada SD, Olopade OI, Lengyel E, Romero IL.

Cancer Prev Res (Phila). 2017 Apr;10(4):255-266. doi: 10.1158/1940-6207.CAPR-16-0281. Epub 2017 Mar 6.

8.

Genetic polymorphisms of enzyme proteins and transporters related to methotrexate response and pharmacokinetics in a Japanese population.

Hashiguchi M, Shimizu M, Hakamata J, Tsuru T, Tanaka T, Suzaki M, Miyawaki K, Chiyoda T, Takeuchi O, Hiratsuka J, Irie S, Maruyama J, Mochizuki M.

J Pharm Health Care Sci. 2016 Dec 9;2:35. eCollection 2016.

9.

Impact of a Multidisciplinary Round Visit for the Management of Dysphagia Utilizing a Wi-Fi-Based Wireless Flexible Endoscopic Evaluation of Swallowing.

Sakakura K, Tazawa M, Otani N, Takagi M, Morita M, Kurosaki M, Chiyoda T, Kanai Y, Endo A, Murata T, Shino M, Yokobori Y, Shirakura K, Wada N, Chikamatsu K.

Ann Otol Rhinol Laryngol. 2017 Jan;126(1):47-53. Epub 2016 Oct 23.

PMID:
27913722
10.

Acute aortic occlusion in a patient with chronic paralysis due to spinal cord injury: a case report.

Yamamoto S, Yokomizo Y, Akai T, Chiyoda T, Goto H, Masaki Y.

Surg Case Rep. 2016 Dec;2(1):121. Epub 2016 Nov 2.

11.

Prognostic Impact of Circulating Tumor Cell Detected Using a Novel Fluidic Cell Microarray Chip System in Patients with Breast Cancer.

Sawada T, Araki J, Yamashita T, Masubuchi M, Chiyoda T, Yunokawa M, Hoshi K, Tao S, Yamamura S, Yatsushiro S, Abe K, Kataoka M, Shimoyama T, Maeda Y, Kuroi K, Tamura K, Sawazumi T, Minami H, Suda Y, Koizumi F.

EBioMedicine. 2016 Sep;11:173-182. doi: 10.1016/j.ebiom.2016.07.027. Epub 2016 Jul 27.

12.

Sex Differences in mRNA Expression of Reduced Folate Carrier-1, Folypolyformyl Glutamate Synthase, and γ-Glutamyl Hydrolase in a Healthy Japanese Population.

Hashiguchi M, Tanaka T, Shimizu M, Tsuru T, Chiyoda T, Miyawaki K, Irie S, Takeuchi O, Hakamata J, Mochizuki M.

J Clin Pharmacol. 2016 Dec;56(12):1563-1569. doi: 10.1002/jcph.760. Epub 2016 May 18.

PMID:
27146084
13.

Retrospective Analysis on the Feasibility and Efficacy of Docetaxel-Cisplatin Therapy for Recurrent Endometrial Cancer.

Ninomiya T, Yamagami W, Susumu N, Makabe T, Sakai K, Wada M, Takigawa A, Chiyoda T, Nomura H, Kataoka F, Hirasawa A, Banno K, Aoki D.

Anticancer Res. 2016 Apr;36(4):1751-8.

PMID:
27069155
14.

Effectiveness of third-line chemotherapy in recurrent ovarian cancer patients.

Yoshihama T, Chiyoda T, Kataoka F, Nomura H, Iguchi Y, Hashimoto S, Yamagami W, Tominaga E, Susumu N, Tsuda H, Aoki D.

Eur J Gynaecol Oncol. 2015;36(4):424-7.

PMID:
26390696
15.

Correction: LATS1 and LATS2 phosphorylate CDC26 to modulate assembly of the tetratricopeptide repeat subcomplex of APC/C.

Masuda K, Chiyoda T, Sugiyama N, Segura-Cabrera A, Kabe Y, Ueki A, Banno K, Suematsu M, Aoki D, Ishihama Y, Saya H, Kuninaka S.

PLoS One. 2015 Apr 10;10(4):e0125308. doi: 10.1371/journal.pone.0125308. eCollection 2015. No abstract available.

16.

LATS1 and LATS2 phosphorylate CDC26 to modulate assembly of the tetratricopeptide repeat subcomplex of APC/C.

Masuda K, Chiyoda T, Sugiyama N, Segura-Cabrera A, Kabe Y, Ueki A, Banno K, Suematsu M, Aoki D, Ishihama Y, Saya H, Kuninaka S.

PLoS One. 2015 Feb 27;10(2):e0118662. doi: 10.1371/journal.pone.0118662. eCollection 2015. Erratum in: PLoS One. 2015;10(4):e0125308. Banno, Koji [corrected to Banno, Kouji].

17.

IGF2 preserves osteosarcoma cell survival by creating an autophagic state of dormancy that protects cells against chemotherapeutic stress.

Shimizu T, Sugihara E, Yamaguchi-Iwai S, Tamaki S, Koyama Y, Kamel W, Ueki A, Ishikawa T, Chiyoda T, Osuka S, Onishi N, Ikeda H, Kamei J, Matsuo K, Fukuchi Y, Nagai T, Toguchida J, Toyama Y, Muto A, Saya H.

Cancer Res. 2014 Nov 15;74(22):6531-41. doi: 10.1158/0008-5472.CAN-14-0914. Epub 2014 Oct 1.

18.

Simultaneous analysis of the gene expression profiles of cancer and stromal cells in endometrial cancer.

Iguchi Y, Ito YM, Kataoka F, Nomura H, Tanaka H, Chiyoda T, Hashimoto S, Nishimura S, Takano M, Yamagami W, Susumu N, Aoki D, Tsuda H.

Genes Chromosomes Cancer. 2014 Sep;53(9):725-37. doi: 10.1002/gcc.22182. Epub 2014 May 10.

PMID:
24817144
19.

[A review of the complications and candida colonization associated with voice rehabilitation using a voice prosthesis].

Miyazaki T, Haji T, Satou S, Ichimaru K, Chiyoda T, Nishimura K, Sakamoto S, Suzuki R, Iwanaga K, Ooba S, Oka A.

Nihon Jibiinkoka Gakkai Kaiho. 2014 Jan;117(1):34-40. Japanese.

PMID:
24601098
20.

Regulation of MKL1 via actin cytoskeleton dynamics drives adipocyte differentiation.

Nobusue H, Onishi N, Shimizu T, Sugihara E, Oki Y, Sumikawa Y, Chiyoda T, Akashi K, Saya H, Kano K.

Nat Commun. 2014 Feb 26;5:3368. doi: 10.1038/ncomms4368.

PMID:
24569594
21.

The APC/C activator Cdh1 regulates the G2/M transition during differentiation of placental trophoblast stem cells.

Naoe H, Chiyoda T, Ishizawa J, Masuda K, Saya H, Kuninaka S.

Biochem Biophys Res Commun. 2013 Jan 11;430(2):757-62. doi: 10.1016/j.bbrc.2012.11.075. Epub 2012 Dec 1.

PMID:
23206702
22.

The origin of stroma surrounding epithelial ovarian cancer cells.

Akahane T, Hirasawa A, Tsuda H, Kataoka F, Nishimura S, Tanaka H, Tominaga E, Nomura H, Chiyoda T, Iguchi Y, Yamagami W, Susumu N, Aoki D.

Int J Gynecol Pathol. 2013 Jan;32(1):26-30. doi: 10.1097/PGP.0b013e3182518533.

PMID:
23202778
23.

LATS1/WARTS phosphorylates MYPT1 to counteract PLK1 and regulate mammalian mitotic progression.

Chiyoda T, Sugiyama N, Shimizu T, Naoe H, Kobayashi Y, Ishizawa J, Arima Y, Tsuda H, Ito M, Kaibuchi K, Aoki D, Ishihama Y, Saya H, Kuninaka S.

J Cell Biol. 2012 May 28;197(5):625-41. doi: 10.1083/jcb.201110110.

24.

Retrospective study comparing irinotecan and pegylated liposomal doxorubicin in treatment of recurrent platinum-refractory/resistant epithelial ovarian cancer.

Nomura H, Tsuda H, Kataoka F, Chiyoda T, Yamagami W, Tominaga E, Susumu N, Aoki D.

Eur J Gynaecol Oncol. 2012;33(1):86-9.

PMID:
22439412
25.

Induction of ZEB proteins by inactivation of RB protein is key determinant of mesenchymal phenotype of breast cancer.

Arima Y, Hayashi H, Sasaki M, Hosonaga M, Goto TM, Chiyoda T, Kuninaka S, Shibata T, Ohata H, Nakagama H, Taya Y, Saya H.

J Biol Chem. 2012 Mar 9;287(11):7896-906. doi: 10.1074/jbc.M111.313759. Epub 2012 Jan 19.

26.

Role of circulating free alu DNA in endometrial cancer.

Tanaka H, Tsuda H, Nishimura S, Nomura H, Kataoka F, Chiyoda T, Tanaka K, Iguchi Y, Susumu N, Aoki D.

Int J Gynecol Cancer. 2012 Jan;22(1):82-6. doi: 10.1097/IGC.0b013e3182328c94.

PMID:
22146763
27.

EGRI and FOSB gene expressions in cancer stroma are independent prognostic indicators for epithelial ovarian cancer receiving standard therapy.

Kataoka F, Tsuda H, Arao T, Nishimura S, Tanaka H, Nomura H, Chiyoda T, Hirasawa A, Akahane T, Nishio H, Nishio K, Aoki D.

Genes Chromosomes Cancer. 2012 Mar;51(3):300-12. doi: 10.1002/gcc.21916. Epub 2011 Nov 17.

PMID:
22095904
28.

Expression profiles of carcinosarcoma of the uterine corpus-are these similar to carcinoma or sarcoma?

Chiyoda T, Tsuda H, Tanaka H, Kataoka F, Nomura H, Nishimura S, Takano M, Susumu N, Saya H, Aoki D.

Genes Chromosomes Cancer. 2012 Mar;51(3):229-39. doi: 10.1002/gcc.20947. Epub 2011 Nov 10.

PMID:
22072501
29.

Successfully treated case of epithelioid sarcoma of the vulva.

Chiyoda T, Ishikawa M, Nakamura M, Ogawa M, Takamatsu K.

J Obstet Gynaecol Res. 2011 Dec;37(12):1856-9. doi: 10.1111/j.1447-0756.2011.01637.x. Epub 2011 Sep 15.

PMID:
21917072
30.

Establishment of a choriocarcinoma model from immortalized normal extravillous trophoblast cells transduced with HRASV12.

Kobayashi Y, Shimizu T, Naoe H, Ueki A, Ishizawa J, Chiyoda T, Onishi N, Sugihara E, Nagano O, Banno K, Kuninaka S, Aoki D, Saya H.

Am J Pathol. 2011 Sep;179(3):1471-82. doi: 10.1016/j.ajpath.2011.05.019. Epub 2011 Jul 23.

31.

Pharmacokinetic and pharmacogenomic profiles of telmisartan after the oral microdose and therapeutic dose.

Ieiri I, Nishimura C, Maeda K, Sasaki T, Kimura M, Chiyoda T, Hirota T, Irie S, Shimizu H, Noguchi T, Yoshida K, Sugiyama Y.

Pharmacogenet Genomics. 2011 Aug;21(8):495-505. doi: 10.1097/FPC.0b013e3283489ce2.

PMID:
21691256
32.

The chemosensitivity of nodal metastases in recurrent epithelial ovarian cancer.

Kataoka F, Tsuda H, Nomura H, Chiyoda T, Tominaga E, Suzuki A, Susumu N, Aoki D.

Eur J Gynaecol Oncol. 2011;32(2):160-3.

PMID:
21614904
33.

Expression of hypoxia-inducible 2 (HIG2) protein in uterine cancer.

Nishimura S, Tsuda H, Nomura H, Kataoka F, Chiyoda T, Tanaka H, Tanaka K, Susumu N, Aoki D.

Eur J Gynaecol Oncol. 2011;32(2):146-9.

PMID:
21614900
34.

Effect of milk on the pharmacokinetics of oseltamivir in healthy volunteers.

Morimoto K, Kishimura K, Nagami T, Kodama N, Ogama Y, Yokoyama M, Toda S, Chiyoda T, Shimada R, Inano A, Kano T, Tamai I, Ogihara T.

J Pharm Sci. 2011 Sep;100(9):3854-61. doi: 10.1002/jps.22627. Epub 2011 May 23.

PMID:
21607954
35.

Microdosing clinical study: pharmacokinetic, pharmacogenomic (SLCO2B1), and interaction (grapefruit juice) profiles of celiprolol following the oral microdose and therapeutic dose.

Ieiri I, Doi Y, Maeda K, Sasaki T, Kimura M, Hirota T, Chiyoda T, Miyagawa M, Irie S, Iwasaki K, Sugiyama Y.

J Clin Pharmacol. 2012 Jul;52(7):1078-89. doi: 10.1177/0091270011408612. Epub 2011 May 18.

PMID:
21593283
36.

The cell cycle regulator Cdh1 controls the pool sizes of hematopoietic stem cells and mature lineage progenitors by protecting from genotoxic stress.

Ishizawa J, Kuninaka S, Sugihara E, Naoe H, Kobayashi Y, Chiyoda T, Ueki A, Araki K, Yamamura K, Matsuzaki Y, Nakajima H, Ikeda Y, Okamoto S, Saya H.

Cancer Sci. 2011 May;102(5):967-74. doi: 10.1111/j.1349-7006.2011.01884.x. Epub 2011 Feb 23.

37.

Overexpression of cofilin 1 can predict progression-free survival in patients with epithelial ovarian cancer receiving standard therapy.

Nishimura S, Tsuda H, Kataoka F, Arao T, Nomura H, Chiyoda T, Susumu N, Nishio K, Aoki D.

Hum Pathol. 2011 Apr;42(4):516-21. doi: 10.1016/j.humpath.2010.07.019. Epub 2011 Jan 14.

PMID:
21237490
38.

Effects of third-line chemotherapy for women with recurrent ovarian cancer who received platinum/taxane regimens as first-line chemotherapy.

Chiyoda T, Tsuda H, Nomura H, Kataoka F, Tominaga E, Suzuki A, Susumu N, Aoki D.

Eur J Gynaecol Oncol. 2010;31(4):364-8.

PMID:
20882873
39.

The anaphase-promoting complex/cyclosome activator Cdh1 modulates Rho GTPase by targeting p190 RhoGAP for degradation.

Naoe H, Araki K, Nagano O, Kobayashi Y, Ishizawa J, Chiyoda T, Shimizu T, Yamamura K, Sasaki Y, Saya H, Kuninaka S.

Mol Cell Biol. 2010 Aug;30(16):3994-4005. doi: 10.1128/MCB.01358-09. Epub 2010 Jun 7.

40.

Lymph node metastasis in grossly apparent stages I and II epithelial ovarian cancer.

Nomura H, Tsuda H, Susumu N, Fujii T, Banno K, Kataoka F, Tominaga E, Suzuki A, Chiyoda T, Aoki D.

Int J Gynecol Cancer. 2010 Apr;20(3):341-5. doi: 10.1111/IGC.0b013e3181cf6271.

PMID:
20375794
41.

The sensitivity and specificity of a new formula to distinguish endometrioid type endometrial carcinoma from ovarian endometrial carcinoma.

Nishimura S, Ito YM, Tsuda H, Ohnishi Y, Kataoka F, Nomura H, Chiyoda T, Suzuki A, Susumu N, Aoki D, Hatae M.

Eur J Obstet Gynecol Reprod Biol. 2010 Jan;148(1):67-72. doi: 10.1016/j.ejogrb.2009.09.016.

PMID:
19815329
42.

Can ABCF2 protein expression predict the prognosis of uterine cancer?

Nishimura S, Tsuda H, Miyagi Y, Hirasawa A, Suzuki A, Kataoka F, Nomura H, Chiyoda T, Banno K, Fujii T, Susumu N, Aoki D.

Br J Cancer. 2008 Nov 18;99(10):1651-5. doi: 10.1038/sj.bjc.6604734.

43.

Pharmacogenetic study of methylenetetrahydrofolate reductase and thymidylate synthase in Japanese and assessment of ethnic and gender differences.

Inoue S, Hashiguchi M, Chiyoda T, Sunami Y, Tanaka T, Mochizuki M.

Pharmacogenomics. 2007 Jan;8(1):41-7.

PMID:
17187508
44.

Sox21 is a repressor of neuronal differentiation and is antagonized by YB-1.

Ohba H, Chiyoda T, Endo E, Yano M, Hayakawa Y, Sakaguchi M, Darnell RB, Okano HJ, Okano H.

Neurosci Lett. 2004 Apr 1;358(3):157-60.

PMID:
15039105
45.

Screening system for urease inhibitors using 13C-NMR.

Chiyoda T, Iida K, Takatori K, Kajiwara M.

Chem Pharm Bull (Tokyo). 1998 Apr;46(4):718-20.

PMID:
9579048
46.

[A case of adult T cell leukemia with calcium deposits in the liver].

Chiyoda T, Morikawa T.

Nihon Naika Gakkai Zasshi. 1990 Nov 10;79(11):1587-8. Japanese. No abstract available.

PMID:
2280139

Supplemental Content

Loading ...
Support Center